Business Daily Media

Biogen Plans Regulatory Filing for Aducanumab in Alzheimer's Disease Based on New Analysis of Larger Dataset from Phase 3 Studies

  • Written by ACN Newswire - Press Releases

image

TOKYO, Oct 23, 2019 - (JCN Newswire) - Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) has announced that, after consulting with the U.S. Food and Drug Administration (FDA), Biogen plans to pursue regulatory approval for aducanumab, an investigational treatment for early Alzheimer's disease (AD). The Phase 3 EMERGE Study met its primary...

Start your own business with Shopify


6 reasons why real estate is the safest long-term investment

An astonishing fact is that ninety percent of millionaires are getting rich by investing in Real Estate. Real estate provides the most reliable pl...

Property

Benefits and Uses of Diamond Tools in Construction

When doing industrial work, you need to use quality and long-lasting equipment. By choosing the lathe machine, you can build a quality and perfect b...

Business Training

Price Analysis of Pacific Palisades Houses

Pacific Palisades is a highly sought-after neighborhood located in the Westside of Los Angeles, California. With its pristine beaches, lush parks...

Property

Constant product innovation is critical to finding market fit

The significant impact the COVID-19 pandemic has had on businesses worldwide is undeniable. Businesses in every industry have been forced to rei...

Business Training

Legal Fees for Selling a House

When you’re looking to sell a house, there are a number of different things you need to take into account before you can do that. One of the main ...

Property

A Closer Look at the Luxurious Tanah Merah New Condo Developments

Tanah Merah New Condo is a luxurious residential development located in the Tanah Merah district of Singapore. This exclusive condominium developmen...

Property